HOME >> MEDICINE >> NEWS
M.D. Anderson collaborates with Federal Ministry of Health in Nigeria

HOUSTON - In a first-of-its-kind trans-Atlantic effort to address cancer disparities among Nigerian and Nigerian-American populations, The University of Texas M. D. Anderson Cancer Center, the Health Disparities Education, Awareness, Research & Training Consortium (HDEART) and the Ministry of Health of the Federal Republic of Nigeria today signed a Memorandum of Understanding (MOU), forming a partnership to collaborate on cancer research, education and training programs in Nigeria.

The agreement was the result of the first cancer conference held in Abuja, Nigeria during October 2006; one of several events marking Nigeria's first National Cancer Awareness Month (October). A delegation from M. D. Anderson Cancer Center in Houston and other US institutions, led by its Center for Research on Minority Health (CRMH), joined representatives from the Ministry of Health, National Hospital, the Nigerian Medical Community, Nigerian Medical Association (Abuja Branch), Nigerian Teaching and other Tertiary care hospitals and the Nigerian Cancer Society to discuss cancer management, early detection and prevention of common cancers, and public education and awareness-building campaigns.

"The Nigerian government's commitment to raising awareness of cancer and addressing cancer issues in West Africa, as evidence by the signing of the MOU, is a critical cornerstone event to begin unraveling cancer and other health-related disparities, particularly diseases affecting Nigerians and African-Americans who share the same genetic heritage," said Dr. Lovell Jones, Director of The Center for Research on Minority Health at M. D. Anderson's Department of Health Disparities Research.

With a large percentage of African-Americans tracing their ancestry to Nigeria and surrounding West African nations, and Houston serving as home to the largest population of Nigerians in the United States, there is "a natural share and learn partnership between M. D. Anderson, one
'"/>

Contact: Claire Tyson
ctyson@mdanderson.org
713-794-1731
University of Texas M. D. Anderson Cancer Center
15-Feb-2007


Page: 1 2 3

Related medicine news :

1. M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
2. M. D. Anderson, BCM, launch research effort targeting asthma and allergic diseases
3. M. D. Anderson teaches the art of aromatherapy to soothe and heal
4. M. D. Anderson: Setting the benchmark in brain tumor treatment
5. International award honors M. D. Anderson President for pioneering research
6. Rice, M. D. Anderson win funds for bench to bed training
7. Newest M.D. Anderson SPORE to fund breast cancer research
8. AstraZeneca and M. D. Anderson Cancer Center form umbrella scientific collaboration agreements
9. Red and Charline McCombs contribute $30 million to M. D. Anderson research effort
10. M. D. Anderson announces collaboration with Indias largest yoga research institution
11. Menzies School of Health Research receives $5.3 million in Federal Budget

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anderson collaborates with Federal Ministry Health Nigeria

(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... Association (AOA) and the Entertainment Industries Council (EIC) ... TV series American Horror Story on a first-of-its-kind ... the dramatic realities of illegal and unsafe lens ... which has already reached tens-of-thousands, is now releasing ...
(Date:7/24/2014)... -- A new formulation of a powerful narcotic painkiller ... drug has been approved by the U.S. Food and ... Purdue Pharma, the pill is a combination of the ... euphoric effects of oxycodone. The naloxone is only activated ... according to the FDA. While Targiniq has only ...
(Date:7/24/2014)... 17, 2014, Cleveland: Could the body,s own immune system ... associated with conditions like chronic epilepsy, Alzheimer,s dementia and ... study published online by PLOS ONE . , ... known as S100B, which serves as a biomarker for ... brain and spinal column. However, following a brain injury, ...
(Date:7/24/2014)... July 24, 2014 National Analysts Worldwide, ... that it will operate globally under the name, ... a woman-owned Employee Stock Ownership Plan (ESOP) organization led ... McDonald, Ph.D . The firm guides market strategy ... analytics. , Said McDonald, “We wanted our name ...
(Date:7/24/2014)... The report, “Feed Palatability Enhancers & Modifiers ... Poultry, Cattle, Pets, Aquaculture, and Others) - Global Trends ... palatability enhancers & modifiers market with an analysis and ... of types of feed flavors, sweeteners, and text rants. ... spread through 275 pages and in-depth TOC on "Feed ...
Breaking Medicine News(10 mins):Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 2Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 4Health News:FDA Approves Hard-to-Abuse Narcotic Painkiller 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 2Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 4
(Date:7/24/2014)...  Blueprint Medicines (Blueprint), a leader in discovering highly ... announced the appointment of Jeffrey Albers as ... Algeta ASA, where he served on the executive management ... Bayer. Mr. Albers succeeds Alexis Borisy , co-founder ... Rock Ventures, who will remain an active member of ...
(Date:7/24/2014)... SAN DIEGO , July 24, 2014 /PRNewswire/ ... the industry leader in bioactive lipid-targeted therapeutics, reported ... trial where ASONEP™ is being investigated as a ... patients that have failed at least one therapy ... and no more than one mTOR inhibitor (e.g., ...
(Date:7/24/2014)... 24, 2014  Market Diagnostics International LLC ("MDxI") ... LabFile , a data resource that sets a ... universe and identifying target In Vitro Diagnostics (IVD) ... that provides IVD manufacturers with accurate and comprehensive ... clear and consistent definitions of laboratory categories and ...
Breaking Medicine Technology:Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2
Cached News: